ECT2 and non-small cell lung carcinoma: The output from the cBioPortal database revealed that ovarian epithelial tumor, non-small cell lung cancer, and cervical cancer were the top three human tumors that experienced genetic alterations in ECT2, with alteration frequency approximately between 16 and 24%.